Cic reduces xct/slc7a11 expression and glutamate release in glioma

HIGHLIGHTS

• who: Jong-Whi Park from the TS603, TS667, were obtained from Memorial Sloan Kettering Cancer Center (MSKCC)SU-AO3, glioma lines were described previously [23]. The patient-derived IDH1-mutant glioma lines were routinely subjected to panel sequencing analysis [26] and immunoblotting to confirm the expression of mutant , (R H). Glioma lines were maintained as neurospheres in NeuroCult (StemCell Technologies) with , u00b5g/ ml heparin sulfate (Sigma), ng/ml of EGF (StemCell Technologies), and , (StemCell Technologies). , cells (provided by Dr. Agarwal, Heidelberg University have published the article: CIC reduces xCT/SLC7A11 expression and glutamate release in glioma, in . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.